product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Grp94 Antibody
catalog :
2104
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
reactivity :
human, mouse, rat
application :
western blot, immunocytochemistry
more info or order :
citations: 9
Published Application/Species/Sample/Dilution | Reference |
---|---|
| |
| |
| |
| |
| |
Chen M, Chiang K, Cheng C, Huang S, Chen Y, Chen T, et al. Antitumor activity of the combination of an HSP90 inhibitor and a PI3K/mTOR dual inhibitor against cholangiocarcinoma. Oncotarget. 2014;5:2372-89 pubmed
| |
product information
SKU :
2104S
Product-Name :
Grp94 Antibody
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, R, Mk
Applications :
Western blot
Product-Category :
Protein Folding and Trafficking
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
100
Host :
Rabbit
Target :
GRp94
Primary-Protein :
GRP94
Alt-Names :
94 kDa glucose-regulated protein,ECGP,ENPL,Endoplasmin,GP96,GRP-94,GRP94,HSP90B1,Heat shock protein 90 kDa beta member 1,TRA1,Tumor rejection antigen 1,Tumor rejection antigen-1 (gp96),endothelial cell (HBMEC) glycoprotein,glucose regulated protein, 94 kDa,gp96 homolog,heat shock protein 90kDa beta (Grp94), member 1,tumor rejection antigen (gp96) 1
more info or order :
company information
Cell Signaling Technology
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.
review
product type
browse more products
questions and comments